Jiangsu Hengrui Medicine Co., Ltd. (SHSE:600276) announces a share repurchase program. Under the program, the company will repurchase not more than CNY 1,200 million worth of its shares. The shares will be repurchased at a price not more than CNY 60.22 per share.

The shares repurchased will be used for ESOP and/or equity incentives. The program will be valid for not more than 12 months.